Sling Therapeutics’ Post

VP-315 - stage 2 clinical trial concept of intratumoral injection that causes necrosis of cutaneous BCC in 1 week. https://lnkd.in/eKwtxsp4

Multicenter randomized clinical trial demonstrates additional ablation lesions surrounding the index effective site significantly reduce OT-PVC recurrence without increasing complications. https://ja.ma/3XVG1a4

In patients with primary hyperparathyroidism, first-line F18-choline PET/CT is a suitable and safe replacement for MIBI SPECT/CT, finds randomized clinical trial. https://ja.ma/4cljYgG

Our latest blog post covers a recent study on the Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy https://lnkd.in/ghMtZhTu Touch can play an important role in the therapeutic use of psychedelic medicines but consent and safety still must be the first priority. See how researchers are rethinking these two key aspects of assisted therapy.

This paper presents the 3-year follow-up results of the ASVS registry following CAG embolization in Asian patients with chronic venous insufficiency Read for more, including clinical efficacy and reintervention rates: https://lnkd.in/dRZQ6wFN #IRad

Reports of suspected side effects are recorded in the spontaneous reporting system. The reports are “spontaneously” documented and reported outside of systematic examinations, e.g. clinical trials. There may be valuable indications (signals) of rare, hitherto unknown side effects. How are signals detected from the reports on suspected side effects? What happens if a signal is detected? The Paul-Ehrlich-Institut answers these questions in the second part of its explanatory video. Find out more 👉 https://lnkd.in/eAFy2eSx

Geographic Atrophy can greatly impact patients’ functioning and quality of life and limit their independence by interfering with activities of daily living, including difficulties with reading, driving, watching television, recognizing faces, and being unable to do household chores. No treatment became available until intravitreal pegcetacoplan was recently approved by the US Food and Drug Administration for GA secondary to AMD. In Europe there is no approved treatment. The design of clinical trials that lead to the approval of new medicines requires well-defined clinical endpoints. I am pleased to share this recent article “Informing Endpoints for Clinical Trials of Geographic Atrophy” in which I had the privilege of co-authoring. https://lnkd.in/djXxmNab

We are looking for patients with Chronic Spontaneous Urticaria (CSU) condition. Visit the link below if you are interested to partake in our clinical trial! https://lnkd.in/g39mUVNd #findaclinicaltrial #clinicalresearchmy #CSU #ChronicSpontaneousUrticaria

💡 Did you know that clinical trials play a crucial role in advancing sarcoma treatment options? Here's what you need to know: 👩⚕️ Who can participate? 🕒 How long do trials typically last? 🛠️ What are the different phases of clinical trials? Explore the FAQs to learn more: https://lnkd.in/dKdv8fT #SarcomaResearch #ClinicalTrials

There is still time to view and receive credit for the Expert Perspectives In The Management of GERD Webcast! Tune in as GiHF faculty discuss key topics including current treatments, limitations of current therapies, and clinical trial data pertaining to GERD. Watch the webcast here: https://loom.ly/0ItqGpI!